Company Filing History:
Years Active: 2012-2018
Title: Takeru Zama: Innovator in Hematology and Oncology
Introduction
Takeru Zama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the fields of hematology and oncology through his innovative research and patented inventions. With a total of 4 patents, Zama's work focuses on methods for producing megakaryocytes, platelets, and thrombopoietin, as well as diagnostic options for head-and-neck tumors.
Latest Patents
Zama's latest patents include a method for producing megakaryocytes and/or platelets using mesenchymal cells. This method allows for the efficient production of these cells in vitro, significantly reducing time and cost. His first invention involves culturing mesenchymal cells in a specialized medium containing iron ions and transporters to collect megakaryocytes and platelets. The second invention focuses on producing thrombopoietin by culturing mesenchymal cells or derived megakaryocytes in a similar medium. Additionally, he has developed a method for producing thrombopoietin from preadipocytes using a specific culturing medium. Furthermore, Zama has disclosed a method for using microRNA as a biomarker for head-and-neck tumors, which includes a kit for tumor determination.
Career Highlights
Throughout his career, Takeru Zama has worked with notable institutions, including Keio University and Adiposeeds, Inc. His research has led to advancements in the understanding and treatment of various medical conditions, particularly in hematology and oncology.
Collaborations
Zama has collaborated with esteemed colleagues such as Yasuo Ikeda and Koichiro Saito. Their joint efforts have contributed to the success of his innovative projects and patents.
Conclusion
Takeru Zama's contributions to medical science through his patents and research have the potential to significantly impact the fields of hematology and oncology. His innovative methods for cell production and tumor diagnosis exemplify the importance of research and development in advancing healthcare solutions.